LETROZOLE
- Product NDC
- 51991-759
- 11-digit product format
- 519910759
- Labeler code
- 51991
- Product ID
- 51991-759_35b275df-f687-4e29-828b-637d5377cc73
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LETROZOLE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA200161
- Marketing category
- ANDA
- Marketing start
- 2011-06-04
- Substance
- LETROZOLE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LETROZOLE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LETROZOLE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7LKK855W8I |
| Rxcui | 200064 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51991-759-10 | LETROZOLE | 1000 in 1 BOTTLE | TABLET | 1000 | | 11 |
| 51991-759-33 | LETROZOLE | 30 in 1 BOTTLE | TABLET | 30 | | 11 |
| 51991-759-90 | LETROZOLE | 90 in 1 BOTTLE | TABLET | 90 | | 11 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LETROZOLE | ACTIVE INGREDIENT | 7LKK855W8I | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| LETROZOLE | ACTIVE MOIETY | 7LKK855W8I | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| POLYETHYLENE GLYCOL 8000 | INACTIVE INGREDIENT | Q662QK8M3B | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51991-759 | LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 11 | Current NDC, Legacy NDC, 3 package rows | 20240327_63e54b62-a30d-4a56-9215-75e7a0b0bf02.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-759-10 | 51991075910 | 1000 TABLET in 1 BOTTLE (51991-759-10) | 1000 tablet | 2011-06-04 | 0000-00-00 | No | No | Current |
| 51991-759-33 | 51991075933 | 30 TABLET in 1 BOTTLE (51991-759-33) | 30 tablet | 2011-06-04 | 0000-00-00 | No | No | Current |
| 51991-759-90 | 51991075990 | 90 TABLET in 1 BOTTLE (51991-759-90) | 90 tablet | 2022-10-01 | 0000-00-00 | No | No | Current |